CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.58
-0.59 (-1.13%)
At close: Dec 2, 2025, 4:00 PM EST
51.61
+0.03 (0.06%)
After-hours: Dec 2, 2025, 7:56 PM EST
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$97,550
Profits / Employee
-$1,242,486
Market Cap
4.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRSP News
- 2 days ago - Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% - The Motley Fool
- 3 days ago - The Best Stocks to Buy With $1,000 Right Now - The Motley Fool
- 11 days ago - 3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential - The Motley Fool
- 13 days ago - Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - The Motley Fool
- 15 days ago - 1 Underrated Stock That Could Soar by 58%, According to Wall Street - The Motley Fool
- 19 days ago - CRISPR Therapeutics Post Q3 Earnings: Testing Investor Patience, But Still A Buy - Seeking Alpha
- 20 days ago - ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? - The Motley Fool
- 22 days ago - CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire